申请人:VenatoRx Pharmaceuticals, Inc.
公开号:US20160264598A1
公开(公告)日:2016-09-15
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
本文中描述的是调节β-内酰胺酶活性的化合物和组合物。在某些实施例中,所述化合物抑制β-内酰胺酶。在某些实施例中,所述化合物在治疗细菌感染方面是有用的。